What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q1 2021?

137 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 113,177,462
Total 13F shares: 41,005,365
Share change: +3,252,600
Total reported value: $259,319,860
Put/Call ratio: 37%
Price per share: $6.32
Number of holders: 137
Value change: +$20,962,700
Number of buys: 63
Number of sells: 59

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ArrowMark Colorado Holdings LLC	13F	Company	7.5%	8,507,790	$47,899,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4.7%	5,316,337	$29,931,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	4.5%	5,072,556	$28,558,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	3%	3,384,516	$19,055,000	—	31 Dec 2020	13F
Park West Asset Management LLC	13F	Company	1.3%	1,491,065	$8,395,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	1.2%	1,350,166	$7,601,000	—	31 Dec 2020	13F
Fiera Capital Corp	13F	Company	0.98%	1,106,860	$6,231,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.86%	973,688	$5,481,000	—	31 Dec 2020	13F
Sio Capital Management, LLC	13F	Company	0.54%	609,780	$3,433,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.41%	463,528	$2,610,000	—	31 Dec 2020	13F
DAFNA Capital Management LLC	13F	Company	0.4%	455,900	$2,567,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.32%	363,980	$2,049,000	—	31 Dec 2020	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	332,645	$1,872,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.29%	327,397	$1,843,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.27%	310,020	$1,746,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.27%	301,597	$1,698,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.26%	299,777	$1,688,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.26%	296,462	$1,670,000	—	31 Dec 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.26%	293,381	$1,652,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.26%	290,220	$1,634,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.25%	277,454	$1,562,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.23%	263,770	$1,485,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.22%	250,614	$1,411,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.2%	223,947	$1,261,000	—	31 Dec 2020	13F
David M. Knott	13F	Individual	0.19%	218,102	$1,228,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.18%	198,359	$1,117,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.17%	191,405	$1,078,000	—	31 Dec 2020	13F
AVIVA PLC	13F	Company	0.17%	188,826	$1,063,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.16%	179,000	$1,008,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.15%	169,142	$953,000	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.12%	132,496	$889,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.14%	155,083	$874,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.13%	150,863	$849,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.13%	147,000	$828,000	—	31 Dec 2020	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.13%	146,826	$827,000	—	31 Dec 2020	13F
Employees Retirement System of Texas	13F	Company	0.12%	138,826	$782,000	—	31 Dec 2020	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.12%	134,845	$759,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	133,300	$750,000	—	31 Dec 2020	13F
ALPS ADVISORS INC	13F	Company	0.12%	131,509	$740,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.11%	128,640	$724,243	—	31 Dec 2020	13F
Cornerstone Capital, Inc.	13F	Company	0.11%	128,465	$723,000	—	31 Dec 2020	13F
SG Americas Securities, LLC	13F	Company	0.11%	126,106	$710,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	120,261	$677,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.09%	101,962	$574,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.09%	99,687	$561,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.08%	89,000	$501,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.08%	86,079	$485,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0.08%	84,899	$478,000	—	31 Dec 2020	13F
WINTON GROUP Ltd	13F	Company	0.07%	83,721	$471,000	—	31 Dec 2020	13F
VIRGINIA RETIREMENT SYSTEMS ET Al	13F	Company	0.07%	83,700	$471,000	—	31 Dec 2020	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q1 2021

As of 31 Mar 2021, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,005,365 shares. The largest 10 holders included ArrowMark Colorado Holdings LLC, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, Park West Asset Management LLC, TWO SIGMA INVESTMENTS, LP, FIERA CAPITAL CORP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and NORTHERN TRUST CORP. This page lists 137 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

136

Q1 2021 holders

137

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.